Publications:

Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Zhao, Ming M; Scott, Stephen S; Evans, Kurt W KW; Yuca, Erkan E; Saridogan, Turcin T; Zheng, Xiaofeng X; Wang, Heping H; Korkut, Anil A; Cruz Pico, Christian X CX; Demirhan, Mehmet M; Kirby, Bryce B; Kopetz, Scott S; Diala, Irmina I; Lalani, Alshad S AS; Piha-Paul, Sarina S; Meric-Bernstam, Funda F

Publication Date: 2021-03-15

Variant appearance in text: TSC2: T1462I

PubMed Link: 33414137

Variant Present in the following documents:

• Main text

View BVdb publication page